Squarepoint Ops LLC - 01 Apr 2026 SCHEDULE 13G Report for LENZ Therapeutics, Inc. Common Stock (LENZ)

Filing Manager
Squarepoint Ops LLC
Reporting Manager
Squarepoint Ops LLC
Security
LENZ Therapeutics, Inc. Common Stock
Symbol
LENZ
Shares outstanding
31,240,118 shares
Disclosed Ownership
1,593,246 shares
Ownership
5.1%
Form type
SCHEDULE 13G
Filing time
08 Apr 2026, 15:07:17 UTC
Date of event
01 Apr 2026
SEC
View on sec.gov

Quoteable Key Fact

"Squarepoint Ops LLC disclosed 5.1% ownership in LENZ Therapeutics, Inc. Common Stock (LENZ) on 01 Apr 2026."

Quick Takeaways

  • Squarepoint Ops LLC filed SCHEDULE 13G for LENZ Therapeutics, Inc. Common Stock (LENZ).
  • Disclosed ownership: 5.1%.
  • Date of event: 01 Apr 2026.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 08 Apr 2026, 15:07.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Squarepoint Ops LLC 5.1% 1,593,246 0 1,593,246 /s/ John Weitzer Chief Compliance Officer
Squarepoint Capital LLP 5.1% 1,593,246 0 1,593,246 /s/ John Weitzer Chief Compliance Officer
Squarepoint Operations Private Limited 5.1% 1,593,246 0 1,593,246 /s/ John Weitzer Chief Compliance Officer
Squarepoint (DIFC) Ltd 5.1% 1,593,246 0 1,593,246 /s/ John Weitzer Chief Compliance Officer
Squarepoint Master Fund Limited 5.1% 1,590,333 0 1,590,333 /s/ John Weitzer Chief Compliance Officer
Squarepoint Core Master Fund Limited 0% 2,913 0 2,913 /s/ John Weitzer Chief Compliance Officer